180 related articles for article (PubMed ID: 28257574)
1. 17β-Hydroxywithanolides as Sensitizers of Renal Carcinoma Cells to Tumor Necrosis Factor-α Related Apoptosis Inducing Ligand (TRAIL) Mediated Apoptosis: Structure-Activity Relationships.
Xu YM; Brooks AD; Wijeratne EM; Henrich CJ; Tewary P; Sayers TJ; Gunatilaka AA
J Med Chem; 2017 Apr; 60(7):3039-3051. PubMed ID: 28257574
[TBL] [Abstract][Full Text] [Related]
2. Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinoma.
Brincks EL; Kucaba TA; James BR; Murphy KA; Schwertfeger KL; Sangwan V; Banerjee S; Saluja AK; Griffith TS
FEBS J; 2015 Dec; 282(24):4747-4765. PubMed ID: 26426449
[TBL] [Abstract][Full Text] [Related]
3. 6-Shogaol enhances renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated cytochrome c release and down-regulation of c-FLIP(L) expression.
Han MA; Woo SM; Min KJ; Kim S; Park JW; Kim DE; Kim SH; Choi YH; Kwon TK
Chem Biol Interact; 2015 Feb; 228():69-78. PubMed ID: 25619640
[TBL] [Abstract][Full Text] [Related]
4. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
Griffith TS; Fialkov JM; Scott DL; Azuhata T; Williams RD; Wall NR; Altieri DC; Sandler AD
Cancer Res; 2002 Jun; 62(11):3093-9. PubMed ID: 12036919
[TBL] [Abstract][Full Text] [Related]
5. Withanolide E sensitizes renal carcinoma cells to TRAIL-induced apoptosis by increasing cFLIP degradation.
Henrich CJ; Brooks AD; Erickson KL; Thomas CL; Bokesch HR; Tewary P; Thompson CR; Pompei RJ; Gustafson KR; McMahon JB; Sayers TJ
Cell Death Dis; 2015 Feb; 6(2):e1666. PubMed ID: 25719250
[TBL] [Abstract][Full Text] [Related]
6. Withanolides from Aeroponically Grown Physalis peruviana and Their Selective Cytotoxicity to Prostate Cancer and Renal Carcinoma Cells.
Xu YM; Wijeratne EMK; Babyak AL; Marks HR; Brooks AD; Tewary P; Xuan LJ; Wang WQ; Sayers TJ; Gunatilaka AAL
J Nat Prod; 2017 Jul; 80(7):1981-1991. PubMed ID: 28617598
[TBL] [Abstract][Full Text] [Related]
7. Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins.
Tewary P; Brooks AD; Xu YM; Wijeratne EMK; Babyak AL; Back TC; Chari R; Evans CN; Henrich CJ; Meyer TJ; Edmondson EF; de Aquino MTP; Kanagasabai T; Shanker A; Gunatilaka AAL; Sayers TJ
Cancer Res; 2021 Jun; 81(12):3374-3386. PubMed ID: 33837043
[TBL] [Abstract][Full Text] [Related]
8. Luteolin sensitizes human 786-O renal cell carcinoma cells to TRAIL-induced apoptosis.
Ou YC; Li JR; Kuan YH; Raung SL; Wang CC; Hung YY; Pan PH; Lu HC; Chen CJ
Life Sci; 2014 Apr; 100(2):110-117. PubMed ID: 24530290
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil.
Mizutani Y; Nakanishi H; Yoshida O; Fukushima M; Bonavida B; Miki T
Eur J Cancer; 2002 Jan; 38(1):167-76. PubMed ID: 11750847
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of TRAIL/Apo2L-mediated apoptosis by adriamycin through inducing DR4 and DR5 in renal cell carcinoma cells.
Wu XX; Kakehi Y; Mizutani Y; Nishiyama H; Kamoto T; Megumi Y; Ito N; Ogawa O
Int J Cancer; 2003 Apr; 104(4):409-17. PubMed ID: 12584736
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitors.
VanOosten RL; Earel JK; Griffith TS
Cancer Gene Ther; 2006 Jun; 13(6):628-32. PubMed ID: 16456549
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of renal carcinoma cells to TRAIL-induced apoptosis by rocaglamide and analogs.
Nalli AD; Brown LE; Thomas CL; Sayers TJ; Porco JA; Henrich CJ
Sci Rep; 2018 Nov; 8(1):17519. PubMed ID: 30504817
[TBL] [Abstract][Full Text] [Related]
13. Eupafolin enhances TRAIL-mediated apoptosis through cathepsin S-induced down-regulation of Mcl-1 expression and AMPK-mediated Bim up-regulation in renal carcinoma Caki cells.
Han MA; Min KJ; Woo SM; Seo BR; Kwon TK
Oncotarget; 2016 Oct; 7(40):65707-65720. PubMed ID: 27582546
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships for withanolides as inducers of the cellular heat-shock response.
Wijeratne EM; Xu YM; Scherz-Shouval R; Marron MT; Rocha DD; Liu MX; Costa-Lotufo LV; Santagata S; Lindquist S; Whitesell L; Gunatilaka AA
J Med Chem; 2014 Apr; 57(7):2851-63. PubMed ID: 24625088
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.
Oya M; Ohtsubo M; Takayanagi A; Tachibana M; Shimizu N; Murai M
Oncogene; 2001 Jun; 20(29):3888-96. PubMed ID: 11439352
[TBL] [Abstract][Full Text] [Related]
16. Selective expression of tumor necrosis factor-related apoptosis-inducing ligand mediated by microRNA suppresses renal carcinoma growth.
Zhang Z; Zhang H; Li H; Chen X; Liu M; Liu D; Zhao Y; Kong X
Mol Cell Biochem; 2014 Jul; 392(1-2):125-34. PubMed ID: 24788726
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer.
Macher-Goeppinger S; Aulmann S; Tagscherer KE; Wagener N; Haferkamp A; Penzel R; Brauckhoff A; Hohenfellner M; Sykora J; Walczak H; Teh BT; Autschbach F; Herpel E; Schirmacher P; Roth W
Clin Cancer Res; 2009 Jan; 15(2):650-9. PubMed ID: 19147771
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors modulate renal cell carcinoma sensitivity to TRAIL/Apo-2L-induced apoptosis by enhancing TRAIL-R2 expression.
VanOosten RL; Moore JM; Karacay B; Griffith TS
Cancer Biol Ther; 2005 Oct; 4(10):1104-12. PubMed ID: 16096370
[TBL] [Abstract][Full Text] [Related]
19. Endoplasmic reticulum stress mediates withaferin A-induced apoptosis in human renal carcinoma cells.
Choi MJ; Park EJ; Min KJ; Park JW; Kwon TK
Toxicol In Vitro; 2011 Apr; 25(3):692-8. PubMed ID: 21266191
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of human renal cell carcinoma cell lines to TRAIL-induced apoptosis by anthracyclines.
Wu XX; Ogawa O; Kakehi Y
Int J Urol; 2004 Mar; 11(3):164-70. PubMed ID: 15009365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]